These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29967542)

  • 21. Dual Function of Phosphoubiquitin in E3 Activation of Parkin.
    Walinda E; Morimoto D; Sugase K; Shirakawa M
    J Biol Chem; 2016 Aug; 291(32):16879-91. PubMed ID: 27284007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.
    Kane LA; Lazarou M; Fogel AI; Li Y; Yamano K; Sarraf SA; Banerjee S; Youle RJ
    J Cell Biol; 2014 Apr; 205(2):143-53. PubMed ID: 24751536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.
    Yamano K; Queliconi BB; Koyano F; Saeki Y; Hirokawa T; Tanaka K; Matsuda N
    J Biol Chem; 2015 Oct; 290(42):25199-211. PubMed ID: 26260794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the structure of PINK1 and the mechanism of ubiquitin phosphorylation.
    Rasool S; Trempe JF
    Crit Rev Biochem Mol Biol; 2018 Oct; 53(5):515-534. PubMed ID: 30238821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural insights into ubiquitin phosphorylation by PINK1.
    Okatsu K; Sato Y; Yamano K; Matsuda N; Negishi L; Takahashi A; Yamagata A; Goto-Ito S; Mishima M; Ito Y; Oka T; Tanaka K; Fukai S
    Sci Rep; 2018 Jul; 8(1):10382. PubMed ID: 29991771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein.
    Biswas R; Bagchi A
    Gene; 2017 Apr; 610():49-58. PubMed ID: 28189762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural insights into Parkin substrate lysine targeting from minimal Miro substrates.
    Klosowiak JL; Park S; Smith KP; French ME; Focia PJ; Freymann DM; Rice SE
    Sci Rep; 2016 Sep; 6():33019. PubMed ID: 27605430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
    Durcan TM; Fon EA
    Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.
    Foote PK; Statsyuk AV
    Curr Protoc Chem Biol; 2018 Sep; 10(3):e45. PubMed ID: 30063295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitination at the lysine 27 residue of the Parkin ubiquitin-like domain is suggestive of a new mechanism of Parkin activation.
    Liu JY; Inoshita T; Shiba-Fukushima K; Yoshida S; Ogata K; Ishihama Y; Imai Y; Hattori N
    Hum Mol Genet; 2022 Aug; 31(15):2623-2638. PubMed ID: 35313349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson's disease.
    Shiba-Fukushima K; Ishikawa KI; Inoshita T; Izawa N; Takanashi M; Sato S; Onodera O; Akamatsu W; Okano H; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(16):3172-3185. PubMed ID: 28541509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PINK1/Parkin-mediated mitophagy in mammalian cells.
    Eiyama A; Okamoto K
    Curr Opin Cell Biol; 2015 Apr; 33():95-101. PubMed ID: 25697963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity.
    Kumar A; Chaugule VK; Condos TEC; Barber KR; Johnson C; Toth R; Sundaramoorthy R; Knebel A; Shaw GS; Walden H
    Nat Struct Mol Biol; 2017 May; 24(5):475-483. PubMed ID: 28414322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms underlying PINK1 and Parkin catalyzed ubiquitylation of substrates on damaged mitochondria.
    Koyano F; Matsuda N
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt B):2791-6. PubMed ID: 25700839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A disease state mutation unfolds the parkin ubiquitin-like domain.
    Safadi SS; Shaw GS
    Biochemistry; 2007 Dec; 46(49):14162-9. PubMed ID: 18004887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering.
    Shiba-Fukushima K; Arano T; Matsumoto G; Inoshita T; Yoshida S; Ishihama Y; Ryu KY; Nukina N; Hattori N; Imai Y
    PLoS Genet; 2014 Dec; 10(12):e1004861. PubMed ID: 25474007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.
    Trempe JF; Chen CX; Grenier K; Camacho EM; Kozlov G; McPherson PS; Gehring K; Fon EA
    Mol Cell; 2009 Dec; 36(6):1034-47. PubMed ID: 20064468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.